Daniel Sundheim D1 Capital Partners
Daniel Sundheim is the founder of D1 Capital Partners, a firm active in public equities and private investments with a growth-oriented focus. He previously was a senior investor at Viking Global before launching D1. The firm’s public portfolio is tracked for exposure to consumer, technology, and other high-quality growth businesses.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clean Harbors
CLH
|
+$274M |
| 2 |
D.R. Horton
DHI
|
+$190M |
| 3 |
Nu Holdings
NU
|
+$172M |
| 4 |
Louisiana-Pacific
LPX
|
+$161M |
| 5 |
LINE
Lineage Inc
LINE
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royal Caribbean
RCL
|
+$229M |
| 2 |
Canadian Pacific Kansas City
CP
|
+$163M |
| 3 |
Synopsys
SNPS
|
+$144M |
| 4 |
Charles River Laboratories
CRL
|
+$117M |
| 5 |
Elevance Health
ELV
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 24.97% |
| 2 | Industrials | 23.89% |
| 3 | Financials | 21.3% |
| 4 | Communication Services | 7.87% |
| 5 | Technology | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
GE HealthCare
GEHC
$33.8B
| $85.9M | 1.19% |
1,159,584
-90,000
| -7% | -$6.27M |
|
27
US Foods
USFD
$23.7B
| $79.5M | 1.1% |
1,032,000
-290,000
| -22% | -$20.7M |
|
28
Kilroy Realty
KRC
$4.25B
| $64.7M | 0.9% |
1,887,000
| – | – |
|
29
Viking Holdings
VIK
$41.4B
| $61.3M | 0.85% |
+1,150,443
| New | +$50.8M |
|
30
Becton Dickinson
BDX
$52.3B
| $57.8M | 0.8% |
335,272
-336,728
| -50% | -$61.7M |
|
31
Affirm
AFRM
$25.8B
| $56.7M | 0.79% |
820,000
| – | – |
|
32
Danaher
DHR
$154B
| $32.1M | 0.45% |
+162,507
| New | +$31.5M |
|
33
Lexeo Therapeutics
LXEO
$400M
| $3.93M | 0.05% |
978,652
| – | – |
|
34
Applied Materials
AMAT
$391B
| – | – |
-205,000
| Closed | -$29.7M |
|
35
Bath & Body Works
BBWI
$3.92B
| – | – |
-2,200,000
| Closed | -$66.7M |
|
36
Cadence Design Systems
CDNS
$87.9B
| – | – |
-198,000
| Closed | -$50.4M |
|
|
37
Canadian Pacific Kansas City
CP
$85B
| – | – |
-2,327,000
| Closed | -$163M |
|
|
38
Charles River Laboratories
CRL
$14.1B
| – | – |
-777,489
| Closed | -$117M |
|
39
Carvana
CVNA
$76.9B
| – | – |
-1,850,000
| Closed | -$77.4M |
|
40
Intel
INTC
$476B
| – | – |
-1,443,000
| Closed | -$32.8M |
|
41
Lennar Class A
LEN
$21B
| – | – |
-468,433
| Closed | -$53.8M |
|
42
Lam Research
LRCX
$393B
| – | – |
-403,000
| Closed | -$29.3M |
|
43
Restaurant Brands International
QSR
$28.2B
| – | – |
-92,833
| Closed | -$6.19M |
|
|
44
Royal Caribbean
RCL
$78.1B
| – | – |
-1,114,713
| Closed | -$229M |
|
|
45
Synopsys
SNPS
$76.2B
| – | – |
-334,700
| Closed | -$144M |
|
46
Warby Parker
WRBY
$3.39B
| – | – |
-257,306
| Closed | -$4.69M |
|
Similar funds
Daniel Sundheim's Q2 2025 Portfolio in Review
As of Q2 2025, Daniel Sundheim held 46 positions worth $7.2B, up 10% from $6.53B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Daniel Sundheim's Q2 2025 filing shows 5 new, 13 increased, 12 reduced and 13 closed positions. Its largest new stake was D.R. Horton: 1,539,410 shares worth $198M. The largest sale was Royal Caribbean, an estimated $229M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, down from 26% a quarter earlier, followed by Industrials and Financials.
- Daniel Sundheim's largest Q2 2025 buy was D.R. Horton: 1,539,410 shares worth $198M.
- Daniel Sundheim added most to Clean Harbors in Q2 2025, an estimated $274M increase.
- Daniel Sundheim's biggest Q2 2025 reduction was Elevance Health, cutting an estimated $101M.
- Daniel Sundheim fully exited Royal Caribbean in Q2 2025, selling an estimated $229M.
- Daniel Sundheim's ten largest holdings make up 56% of its $7.2B portfolio in Q2 2025.
- Daniel Sundheim opened 5 new positions and closed 13 in Q2 2025.
- Daniel Sundheim's portfolio value rose 10% quarter-over-quarter to $7.2B.
Based on D1 Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.